Zoledronic Acid Prevents Cancer Treatment-Induced Bone Loss in Breast Cancer Patients Treated with Hormone Therapy
San Antonio, Texas (ots) - - First Data from Large Trial in Premenopausal Women Show Strong Protective Effect Zoledronic acid prevents loss of bone mass caused by adjuvant treatment with an aromatase inhibitor or tamoxifen and the luteinising hormone-releasing hormone analog (LHRHa) goserelin ...
mehr